Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

Nail issues are common in alopecia areata patients.

Alopecia Areata is a hair loss condition affecting all genders, often linked to other diseases, with treatments available but varying success rates.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Dermatopathia pigmentosa reticularis causes skin discoloration, hair loss, and nail problems.

Systemic steroids effectively treated severe nail issues in a card illusionist with alopecia areata.

About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

A young woman's Cronkhite-Canada syndrome improved on its own after she gave birth.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

HIV can cause skin disorders, which are often the first sign of infection, especially in people with darker skin.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

Up to 50% of scalp hair can be lost before it appears thin, and treatment is only needed for hair loss caused by diseases or deficiencies.

The document concludes that proper treatment and management of plaque psoriasis in adolescents can improve their quality of life.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Skin changes are key for early diagnosis and treatment of rheumatic diseases.

Higher IL-17A levels indicate more severe alopecia areata.

The document explains various skin conditions and their treatments.

Laser treatment is safe and can effectively treat toenail fungus, especially when combined with other treatments if no improvement is seen after about a year.

New treatments targeting specific genes show promise for treating keratin disorders.

Children with HIV often have skin problems that can indicate the severity of their immune system damage.